Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Buske1, V. Leblond2, M. Dimopoulos3, E. Kimby4, U. Jäger5 & M. Dreyling6, on behalf of the ESMO Guidelines Working Group* Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany; Departement of Hematology Pitié Salpêtrière Hospital, Pierre et Marie Curie University, UPMC GRC11-GRECHY, 75013 Paris, France; Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra Hospital, Athens, Greece; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet and The Hematology Center, Karolinska University Hospital, Stockholm, Sweden; Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna (MUW), Vienna, Austria; Department of Medicine III, University Hospital Grosshadern, LMU Munich, Germany